New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Taro Pharmaceutical Industries Ltd.
TARO
Shape
US Flag

NYSE

2B

Drug Manufacturers - Specialty & Generic

Next Earning date - 23 Jan 2025

2B

Drug Manufacturers - Specialty & Generic

Next Earning date - 23 Jan 2025

42.98USD
Shape0.01 ( 0.01%)
favorite-chart

Relative Strenght

52
favorite-chart

Volume Buzz

347%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

6%

Quote Panel

Shape
Updated October 26, 2024
1W % 1M % 3M % 1Y 31.13 %

Key Metrics

Shape
  • Market Cap

    1.62B


  • Shares Outstanding

    37.58M


  • Share in Float

    8.09M


  • Dividende

    0


  • Earning Date

    23 Jan 2025


  • Price Target

    42.975


  • Average Volume

    32927


  • Beta

    0.557


  • Range

    32.67-45.76


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.taro.com


  • Sector

    Healthcare


Fundamentals

Shape

24.55x

P/E Ratio

2.57x

P/S Ratio

0.90x

P/B Ratio

0.0

Debt/Equity

8.6%

Net Margin

$1.4

EPS

How TARO compares to sector?

P/E Ratio

Relative Strength

Shape

TARO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$628M

Shape281%

2025-Revenue

0

$244M

Shape1251%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

-66%

0.37
vs 1.09

Q3.22

arrow
arrow

N/A

-0.07
vs 0.66

Q4.22

arrow
arrow

-73%

0.19
vs 0.7

Q1.23

arrow
arrow

-75%

0.18
vs 0.73

Q2.23

arrow
arrow

+8%

0.4
vs 0.37

Q3.23

arrow
arrow

+643%

0.38
vs -0.07

Q4.23

arrow
arrow

+184%

0.54
vs 0.19

Q1.24

arrow
arrow

+139%

0.43
vs 0.18

Q3.24

arrow
arrow

+253%

1.34
vs 0.38

Q4.24

arrow
arrow

+185%

1.54
vs 0.54

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+6%

156.7M  vs 147.1M

Q3.22

arrow
arrow

-1%

130.5M  vs 132M

Q4.22

arrow
arrow

+0%

139.2M  vs 139M

Q1.23

arrow
arrow

+2%

146.6M  vs 143.3M

Q2.23

arrow
arrow

+1%

158.9M  vs 156.7M

Q3.23

arrow
arrow

+14%

148.2M  vs 130.5M

Q4.23

arrow
arrow

+13%

157.1M  vs 139.2M

Q1.24

arrow
arrow

+13%

164.9M  vs 146.6M

Q3.24

arrow
arrow

+11%

164.9M  vs 148.2M

Q4.24

arrow
arrow

+5%

164.8M  vs 157.1M

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

+1%

0.01
vs 0.02

Q3.22

arrow
arrow

0%

-0.00
vs 0.01

Q4.22

arrow
arrow

+0%

0
vs -0.00

Q1.23

arrow
arrow

+0%

0
vs 0

Q2.23

arrow
arrow

+1%

0.01
vs 0

Q3.23

arrow
arrow

+0%

0
vs 0.01

Q4.23

arrow
arrow

+1%

0.01
vs 0

Q1.24

arrow
arrow

+1%

0.01
vs 0.01

Institutionnal OwnershipShape

status-upQoQ

Q2.22

arrow
arrow

68

68
vs 63

8%

Q3.22

arrow
arrow

64

64
vs 68

-6%

Q4.22

arrow
arrow

59

59
vs 64

-8%

Q1.23

arrow
arrow

59

59
vs 59

NA

Q2.23

arrow
arrow

71

71
vs 59

20%

Q3.23

arrow
arrow

80

80
vs 71

13%

Q4.23

arrow
arrow

88

88
vs 80

10%

Q1.24

arrow
arrow

94

94
vs 88

7%

Earnings Growth

Latest News